- English
- French
- German
- Portuguese
- Spanish
- Russian
- Japanese
- Korean
- Arabic
- Irish
- Greek
- Turkish
- Italian
- Danish
- Romanian
- Indonesian
- Czech
- Afrikaans
- Swedish
- Polish
- Basque
- Catalan
- Esperanto
- Hindi
- Lao
- Albanian
- Amharic
- Armenian
- Azerbaijani
- Belarusian
- Bengali
- Bosnian
- Bulgarian
- Cebuano
- Chichewa
- Corsican
- Croatian
- Dutch
- Estonian
- Filipino
- Finnish
- Frisian
- Galician
- Georgian
- Gujarati
- Haitian
- Hausa
- Hawaiian
- Hebrew
- Hmong
- Hungarian
- Icelandic
- Igbo
- Javanese
- Kannada
- Kazakh
- Khmer
- Kurdish
- Kyrgyz
- Latin
- Latvian
- Lithuanian
- Luxembou..
- Macedonian
- Malagasy
- Malay
- Malayalam
- Maltese
- Maori
- Marathi
- Mongolian
- Burmese
- Nepali
- Norwegian
- Pashto
- Persian
- Punjabi
- Serbian
- Sesotho
- Sinhala
- Slovak
- Slovenian
- Somali
- Samoan
- Scots Gaelic
- Shona
- Sindhi
- Sundanese
- Swahili
- Tajik
- Tamil
- Telugu
- Thai
- Ukrainian
- Urdu
- Uzbek
- Vietnamese
- Welsh
- Xhosa
- Yiddish
- Yoruba
- Zulu
Founded in MMIX, Jymed est Pharmaceutical Enterprise in Sina quod integrates R & D, vestibulum, commercialization et mos progressionem et vestibulum peptide products. In comitatu est circa DLXX employees, cum Core Management Team composito ex doctorum cum pharmaceutical peritiam et super XX annos experientia in peptide industria. Jymed operatur unus investigationis centrum et duos major productio facilities, consequi multi-ton scale productio facultatem in peptides, positioning ut an industria princeps.
Jurridus
productus
Peptide apis
Peptide apis
JMED praebet diverse portfolio de peptide Apis, comprehendo super XX varietates ut semaglutide, Tirzepatide, Liraglutide, Degarelix et Oxytocin. Inter haec, quinque products, inter semaglutide et Tirzepatide, feliciter perficitur FDA medicamento Magister file (DMF) adnotatione.
COLOR peptide
COLOR peptide
JMMED offert High-qualitas COLOR peptides, rudis materiae, et oem formula servicia ex investigationis gradu ad CGMP gradu, omnes cum restrictius qualitas imperium. Nostrum Saccharum peptides, clarus pro sua salute et otium of modificatio, sunt essential ingredients in medicamine industria, tradens proven beneficia ad capillos cura, vulnus sanitatem, anti-senescit, anti-sanitatem, albentes et eyelash.
Cro & CDmo Service
Cro & CDmo Service
JYMed has a comprehensive and efficient peptide industrialization system, offering clients full-spectrum services for peptide and peptide-analog products, including the research and production of therapeutic peptides, veterinary peptides, cosmetic peptides, and RNA, along with support for registration and regulatory compliance .
Custom Peptide
Custom Peptide
Ut mos-orientatur inceptum, jymmed habet comprehensive peptide industrializationem ratio, cum super XX annis experientia in peptide R & D et statum-of-in-arte facilities. We provide a full range of high quality peptides based on the client's need：The quantity from mg to kg, the purity from crude to >99%, from non-GMP to GMP grade, from simple peptides to modified peptides, antigenic peptides development, Confidiis pactum est available.
De
Jurridus
Introductio de JMED, A US FDA inspected peptide manufacturer. Featured Products: COLOR peptides, peptide Apis, Custom Peptides, ut, Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK, CUSTYL HEXAPEPIDIDE, VIII, etc,
Email: jymed@jymedtech.com
-
Qualitas fide
Qualitas fide
Details Details -
Regulatory Affairs Support
Regulatory Affairs Support
Details Details -
ADVENTIA in R & D et Commercialization
ADVENTIA in R & D et Commercialization
Details Details -
Patents
Patents
Details Details -
Qualification testimoniales
Qualification testimoniales
Details Details
News and Information
Jymed invitationes ad Pchi MMXXV in Guangzhou
Jymmed sincere invitat vos adiungere nobis ad MMXXV Pchi medicamine Ingredients in Guangzhou explorarent tardus foro trends, innovative technologiae et internationalis ordinationes. Visita nos in umbraculum 6j07! In MMXXV Guan ...
Excitando nuntium | Jymed scriptor peptide productio facilitas recipit WC Certification
Nuper, Jymed scriptor Peptide productio facilitas, Hubei Jianxiang Biopharmaceutical Co., Ltd., accepit duo publica documenta edita ab Hubei provinciarum medicamentis administratione, in "E Gmp Gmp 2024-260) A ...
Excitando nuntium | Sinis scriptor maximae semaglutide API productio facilitas transit US FDA inspectionem
A Augusti XXVI ad August XXX, MMXXIV, jymmed scriptor peptide productio facilitas, Hubei Jx bio-pharmaceutical Co., Ltd., feliciter Transierunt an on-site inspectionem conducted per US cibum et medicamento administratione (FDA). Et inspectionem operuit key areas ...
